.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Carter's Aromatherapy Designs (C.A.D.) is stocked at 34 licensed dispensaries across California, with the deepest coverage in Sacramento, Modesto, Stockton, Marysville, and Turlock. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Carter's Aromatherapy Designs (C.A.D.) concentrated 64.95% of sales in Topical, with Tincture & Sublingual at 30.54% and Capsules at 4.51%; within that mix, Topical grew 20.48% year over year and 30.37% month over month, while Tincture & Sublingual rose 5.41% YoY and 31.82% MoM. Capsules surged 199.02% YoY but only 5.44% MoM, indicating a small base despite acceleration, and the brand’s overall average price rose 29.75% YoY to $44.12 alongside brand-level sales growth of 18.50% YoY; taken together, the heavier-weight Topical engine and simultaneous MoM lifts across all three categories imply the brand is leaning into higher-priced relief formats while maintaining breadth in adjunct formats.
Positioning-wise, a 64.95% Topical share coupled with a California Topical rank of 5 suggests the brand is competing from a specialist foothold rather than a generalist spread, and the 31.82% MoM uplift in Tincture & Sublingual alongside a 30.37% MoM in Topical points to demand that is responsive to price-tiered comfort use cases. With brand sales up 18.50% YoY but down 11.95% over 24 months, the current mix skews toward short-cycle recovery driven by higher-ticket Topical (average price $58.51) while Capsules’ 199.02% YoY on a 4.51% share indicates room to build a lower-price entry ramp; the pattern implies near-term share defense in Topical with optionality to diversify risk by nudging Capsules toward a mid-tier role.
Competitive Landscape
Carter's Aromatherapy Designs (C.A.D.) sits at rank #5 in CA Topical for September 2026, down 1 position from #4 a year earlier, and unchanged from #5 three months ago, while its peak of #4 in January 2026 indicates a 1-rank slippage since the start of the year; in contrast, Papa & Barkley held #1 year over year with a -1.5% sales YoY shift and Sweet ReLeaf (CA) climbed from #5 to #4 with a 30.2% YoY sales increase, outpacing Buddies at #3 despite Buddies’ 15.9% YoY growth; paired with Mary's Medicinals steady hold at #2 and a -0.4% YoY sales change, the mix of a competitor gaining 1 rank and another maintaining #1 while trimming sales suggests C.A.D.’s flat three-month rank and 1-rank YoY decline reflect pressure from faster-growing mid-tier rivals rather than broad category contraction.
Notable Products
Tranquility Tincture (1000mg THC, 2mg CBD, 29ml) delivered the largest month-over-month move in September 2026 with +161% growth to rank 1, while CBD Elevation Capsules 10-Pack (580mg CBD) slid -19% to rank 6; this divergence, alongside Nana's Unscented Greaze at +118% reaching rank 3, signals a pivot toward higher-THC and therapeutic topical formats over CBD-only capsules. Three of the top five ranks are in Tincture & Sublingual, and Topicals occupy ranks 2-4, indicating a two-pillar mix where rapid tincture acceleration (+161% at rank 1 vs. +40% at rank 5 for a CBN/THC tincture) is complemented by mid-to-high double-digit topical gains (+118% at rank 3 vs. +43% at rank 4); the single capsule decline at -19% contrasts with these gains. The concentration of Topicals in four of the top ten, combined with two tinctures in the top five, implies Carter's Aromatherapy Designs (C.A.D.) is consolidating share around fast-moving relief and nighttime formats rather than daily CBD supplementation, a direction that favors potency-forward SKUs and targeted use-cases.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
